ウイルスろ過市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

ウイルスろ過市場は、2023年に21億9,000万米ドルと評価され、2024年には24億9,000万米ドルに達すると予測され、CAGR 14.35%で成長し、2030年には56億米ドルになると予測されています。

ウイルスろ過は、特にウイルスの安全性を確保するための生物学的製剤の精製において、より広範なバイオプロセスおよびバイオテクノロジーの展望の重要な構成要素です。このプロセスには、生物学的材料からウイルス汚染物質を除去することが含まれ、ワクチン、モノクローナル抗体、治療用タンパク質などの安全で効果的なバイオ医薬品の製造に不可欠です。ウイルスろ過の必要性は、生物学的製品に感染リスクをもたらす可能性のあるウイルスが含まれていないことを保証する厳しい規制基準に起因しています。用途は製薬製造、バイオテクノロジー研究、飲食品産業と多岐にわたり、最終用途はワクチン製造や遺伝子治療に重点を置くヘルスケア施設やバイオ製薬会社です。

市場の成長は、主に慢性疾患の有病率の増加と生物製剤の需要増に影響され、厳格なウイルスクリアランス方法の必要性を煽っています。さらに、ナノ濾過や膜の多孔性向上などのフィルター技術の進歩は、濾過効率と製品収率を向上させる有利な機会をもたらしています。しかし、高い運用コスト、規制上のハードル、既存のプロセスにろ過システムを組み込むことの複雑さなどの課題が、市場拡大の妨げになる可能性があります。また、新種のウイルス株が次々と出現していることも状況をさらに複雑にしており、継続的な研究開発が必要となっています。

市場機会を活用するためには、シングルユースろ過や自動化技術のような革新的なろ過ソリューションに投資することが推奨されます。さらに、より広範なウイルスを効率的に捕捉できる、より堅牢なろ過媒体の開発研究を拡大することも有望です。また、企業は規制機関と協力して、製品開拓を新興国市場の規格に合わせることで、コンプライアンスを確保し、市場参入を促進すべきです。ウイルスろ過市場は、急速な技術進歩と需要の変化を特徴とするダイナミックな市場であるため、利害関係者は柔軟性と適応性を維持する必要があります。費用対効果に優れ、拡張性のあるソリューションを重視することが、この重要な分野の成長を維持するために不可欠です。

市場力学：急速に進化するウイルスろ過市場の主要市場インサイトを公開

ウイルスろ過市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬業界の急成長
  • 慢性疾患の増加
  • この分野への研究開発投資と取り組みの拡大
• 市場抑制要因
  • ウイルスろ過機能に一定の限界
• 市場機会
  • 製薬アウトソーシング業界における大きな可能性
  • シングルユース製品/技術への傾斜
• 市場の課題
  • 継続的なウイルスろ過の検証

ポーターの5つの力：ウイルスろ過市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ウイルスろ過市場における外部からの影響の把握

外部マクロ環境要因は、ウイルスろ過市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ウイルスろ過市場における競合情勢の把握

ウイルスろ過市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスウイルスろ過市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ウイルスろ過市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ウイルスろ過市場における成功への道筋を描く

ウイルスろ過市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬業界の急速な成長
    • 慢性疾患の増加
    • 研究開発投資と分野における取り組みの拡大
  • 抑制要因
    • ウイルスろ過機能には一定の制限があります
  • 機会
    • 医薬品アウトソーシング業界の主な範囲
    • 使い捨て製品/技術への傾向
  • 課題
    • 継続的なウイルスろ過の検証
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ウイルスろ過市場：製品別

• 濾過システム
• キットと試薬

第7章 ウイルスろ過市場：用途別

• 空気清浄
• 生物製剤
• 医療機器
• 水の浄化

第8章 ウイルスろ過市場：エンドユーザー別

• バイオテクノロジー企業
• 契約調査機関
• 医療機器企業
• 製薬

第9章 南北アメリカのウイルスろ過市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のウイルスろ過市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのウイルスろ過市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Argonide Corporation
• Asahi Kasei Medical Co., Ltd.
• Charles River Laboratories International, Inc.
• Clean Cells SAS
• Danaher Corporation
• Freudenberg Filtration Technologies SE & Co. KG
• GE Healthcare
• Lonza Group AG
• MANN+HUMMEL International GmbH & Co. KG
• Merck KGaA
• Non-Change Enterprise Co., Ltd.
• Parker Hannifin Corporation
• Sartorius AG
• Synder Filtration, Inc.
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. VIRUS FILTRATION MARKET RESEARCH PROCESS
• FIGURE 2. VIRUS FILTRATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VIRUS FILTRATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VIRUS FILTRATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VIRUS FILTRATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VIRUS FILTRATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES VIRUS FILTRATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES VIRUS FILTRATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. VIRUS FILTRATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. VIRUS FILTRATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VIRUS FILTRATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VIRUS FILTRATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VIRUS FILTRATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VIRUS FILTRATION MARKET DYNAMICS
• TABLE 7. GLOBAL VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VIRUS FILTRATION MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VIRUS FILTRATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VIRUS FILTRATION MARKET SIZE, BY AIR PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VIRUS FILTRATION MARKET SIZE, BY BIOLOGICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VIRUS FILTRATION MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VIRUS FILTRATION MARKET SIZE, BY WATER PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VIRUS FILTRATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VIRUS FILTRATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VIRUS FILTRATION MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VIRUS FILTRATION MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. CANADA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES VIRUS FILTRATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CHINA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDIA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ITALY VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. POLAND VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. QATAR VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM VIRUS FILTRATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. VIRUS FILTRATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. VIRUS FILTRATION MARKET, FPNV POSITIONING MATRIX, 2023

The Virus Filtration Market was valued at USD 2.19 billion in 2023, expected to reach USD 2.49 billion in 2024, and is projected to grow at a CAGR of 14.35%, to USD 5.60 billion by 2030.

Virus filtration is a critical component of the broader bioprocessing and biotechnology landscape, particularly in the purification of biological products to ensure viral safety. This process encompasses the removal of viral contaminants from biological materials, which is crucial for the production of safe and effective biopharmaceuticals, including vaccines, monoclonal antibodies, and therapeutic proteins. The necessity of virus filtration stems from stringent regulatory standards ensuring that biological products are free of viruses that may pose infection risks. Applications extend across pharmaceutical manufacturing, biotechnology research, and food & beverage industries, with significant end-use in healthcare facilities and biopharmaceutical companies focused on vaccine production and gene therapies.

Market growth is primarily influenced by the increasing prevalence of chronic diseases and the rising demand for biologics, which fuel the need for rigorous viral clearance methods. Additionally, advancements in filter technologies, such as nanofiltration and improved membrane porosity, present lucrative opportunities for enhancing filtration efficiency and product yields. However, challenges such as high operational costs, regulatory hurdles, and the complexity of integrating filtration systems into existing processes can impede market expansion. The continuous emergence of new viral strains further complicates the landscape, necessitating ongoing research and development.

To capitalize on market opportunities, it is recommended to invest in innovative filtration solutions like single-use filtration and automation technologies, which can streamline operations and reduce contamination risks. Additionally, expanding research into the development of more robust filtration media that can efficiently capture a broader range of viruses holds promising potential. Companies should also collaborate with regulatory bodies to align product development with evolving standards, ensuring compliance and facilitating market entry. The virus filtration market remains dynamic, characterized by rapid technological advances and shifting demands, requiring stakeholders to maintain flexibility and adaptability. Emphasizing cost-effective, scalable solutions will be crucial for sustaining growth in this crucial sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Virus Filtration Market

The Virus Filtration Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rapid growth in pharmaceutical industry
  • Increasing prevalence of chronic diseases
  • Growth in R&D investment and efforts in the field
• Market Restraints
  • Certain limits in virus filtration capability
• Market Opportunities
  • Major scope in pharmaceutical outsourcing industry
  • Inclination towards the single-use product/technology
• Market Challenges
  • Validation of continuous virus filtration

Porter's Five Forces: A Strategic Tool for Navigating the Virus Filtration Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Virus Filtration Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Virus Filtration Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Virus Filtration Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Virus Filtration Market

A detailed market share analysis in the Virus Filtration Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Virus Filtration Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Virus Filtration Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Virus Filtration Market

A strategic analysis of the Virus Filtration Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Virus Filtration Market, highlighting leading vendors and their innovative profiles. These include Argonide Corporation, Asahi Kasei Medical Co., Ltd., Charles River Laboratories International, Inc., Clean Cells SAS, Danaher Corporation, Freudenberg Filtration Technologies SE & Co. KG, GE Healthcare, Lonza Group AG, MANN+HUMMEL International GmbH & Co. KG, Merck KGaA, Non-Change Enterprise Co., Ltd., Parker Hannifin Corporation, Sartorius AG, Synder Filtration, Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Virus Filtration Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Filtration Systems and Kits & Reagents.
• Based on Application, market is studied across Air Purification, Biologicals, Medical Devices, and Water Purification.
• Based on End User, market is studied across Biotechnology Companies, Contract Research Organizations, Medical Device Companies, and Pharmaceutical.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rapid growth in pharmaceutical industry
    • 5.1.1.2. Increasing prevalence of chronic diseases
    • 5.1.1.3. Growth in R&D investment and efforts in the field
  • 5.1.2. Restraints
    • 5.1.2.1. Certain limits in virus filtration capability
  • 5.1.3. Opportunities
    • 5.1.3.1. Major scope in pharmaceutical outsourcing industry
    • 5.1.3.2. Inclination towards the single-use product/technology
  • 5.1.4. Challenges
    • 5.1.4.1. Validation of continuous virus filtration
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Virus Filtration Market, by Product

• 6.1. Introduction
• 6.2. Filtration Systems
• 6.3. Kits & Reagents

7. Virus Filtration Market, by Application

• 7.1. Introduction
• 7.2. Air Purification
• 7.3. Biologicals
• 7.4. Medical Devices
• 7.5. Water Purification

8. Virus Filtration Market, by End User

• 8.1. Introduction
• 8.2. Biotechnology Companies
• 8.3. Contract Research Organizations
• 8.4. Medical Device Companies
• 8.5. Pharmaceutical

9. Americas Virus Filtration Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Virus Filtration Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Virus Filtration Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Argonide Corporation
• 2. Asahi Kasei Medical Co., Ltd.
• 3. Charles River Laboratories International, Inc.
• 4. Clean Cells SAS
• 5. Danaher Corporation
• 6. Freudenberg Filtration Technologies SE & Co. KG
• 7. GE Healthcare
• 8. Lonza Group AG
• 9. MANN+HUMMEL International GmbH & Co. KG
• 10. Merck KGaA
• 11. Non-Change Enterprise Co., Ltd.
• 12. Parker Hannifin Corporation
• 13. Sartorius AG
• 14. Synder Filtration, Inc.
• 15. Thermo Fisher Scientific, Inc.